{"id":2710,"date":"2021-09-01T18:13:21","date_gmt":"2021-09-01T18:13:21","guid":{"rendered":"http:\/\/mcaureate.com\/?page_id=2710"},"modified":"2024-06-26T01:22:16","modified_gmt":"2024-06-26T01:22:16","slug":"team-2","status":"publish","type":"page","link":"https:\/\/aureatesf.com\/?page_id=2710","title":{"rendered":"Our Team"},"content":{"rendered":"\n<h6 class=\"wp-block-heading\">&nbsp;<\/h6>\n\n\n\n<div class=\"wp-block-columns are-vertically-aligned-top is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-top has-small-font-size is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/aureatesf.com\/wp-content\/uploads\/2023\/10\/Headshot-Austin-bg-circleUntitled-design-19.svg\" alt=\"\" class=\"wp-image-17640\" style=\"aspect-ratio:1;width:192px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">Austin Milliken<\/h2>\n\n\n\n<p class=\"has-text-align-center has-medium-font-size\">Founder<\/p>\n\n\n\n<p class=\"has-text-align-center\">Startup Specialist <\/p>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\">VC Placements<\/p>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\">Options Strategist<\/p>\n\n\n\n<p class=\"has-text-align-center\"><\/p>\n\n\n\n<p class=\"has-text-align-center\">Series 7, 63, 65<\/p>\n\n\n\n<p class=\"has-text-align-center\">GARP FRM<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-top has-small-font-size is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/aureatesf.com\/wp-content\/uploads\/2023\/10\/Headshot-JD-bg-circle2.svg\" alt=\"\" class=\"wp-image-17628\" style=\"aspect-ratio:1;width:189px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">John Davis<\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-medium-font-size\">Partner<\/h3>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-small-font-size\">Biotech \/ Healthcare<\/h3>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-small-font-size\">Secondary Shares<\/h3>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-small-font-size\">Institutional Trading<\/h3>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-small-font-size\"><br>Series 7, 65, 66<\/h3>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-top has-small-font-size is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image is-style-rounded\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/aureatesf.com\/wp-content\/uploads\/2023\/10\/Headshot-al_minafo_bg-cirlce_-grey-svg.svg\" alt=\"\" class=\"wp-image-17629\" style=\"aspect-ratio:1;object-fit:cover;width:182px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">Al Minafo<\/h2>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-medium-font-size\">Director of East Coast Business\u00a0Development<\/h3>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center has-small-font-size\">Hedge Fund Specialist<\/h3>\n\n\n\n<p class=\"has-text-align-center\">Secondary Shares<\/p>\n\n\n\n<p class=\"has-text-align-center\">Derivatives<\/p>\n<\/div>\n<\/div>\n\n\n\n<h6 class=\"wp-block-heading\">&nbsp;<\/h6>\n\n\n\n<h6 class=\"wp-block-heading\">&nbsp;<a href=\"mailto:al@aureatesf.com\" rel=\"nofollow\"><br><\/a><br><a href=\"https:\/\/www.linkedin.com\/in\/al-minafo-60a6465\/\" rel=\"nofollow\"><br><\/a><\/h6>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Austin Milliken Founder Startup Specialist VC Placements Options Strategist Series 7, 63, 65 GARP FRM John Davis Partner Biotech \/ Healthcare Secondary Shares Institutional Trading Series 7, 65, 66 Al Minafo Director of East Coast Business\u00a0Development Hedge Fund Specialist Secondary Shares Derivatives &nbsp; &nbsp;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-2710","page","type-page","status-publish","hentry"],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/pages\/2710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aureatesf.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2710"}],"version-history":[{"count":4,"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/pages\/2710\/revisions"}],"predecessor-version":[{"id":17733,"href":"https:\/\/aureatesf.com\/index.php?rest_route=\/wp\/v2\/pages\/2710\/revisions\/17733"}],"wp:attachment":[{"href":"https:\/\/aureatesf.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}